• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

无抗凝的清醒体外膜肺氧合用于治疗几乎完全阻塞性气管鳞状细胞癌。

Awake ECMO without anticoagulation for nearly completely obstructive squamous cell carcinoma of the trachea.

作者信息

Klug Theodore D, Craig John, Shires Courtney B

机构信息

West Cancer Center Germantown TN USA.

Baptist Medical Group Memphis TN USA.

出版信息

Clin Case Rep. 2020 Nov 6;9(1):164-168. doi: 10.1002/ccr3.3490. eCollection 2021 Jan.

DOI:10.1002/ccr3.3490
PMID:33489153
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7813012/
Abstract

Awake veno-venous ECMO without anticoagulation is a safe and successful way to remove a significantly obstructive malignancy in the trachea.

摘要

清醒状态下无抗凝的静脉-静脉体外膜肺氧合是清除气管内显著阻塞性恶性肿瘤的一种安全且成功的方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2334/7813012/51a22befc968/CCR3-9-164-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2334/7813012/d63013835278/CCR3-9-164-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2334/7813012/129e8ba87bdf/CCR3-9-164-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2334/7813012/c76737748466/CCR3-9-164-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2334/7813012/fc7cf9d94d50/CCR3-9-164-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2334/7813012/51a22befc968/CCR3-9-164-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2334/7813012/d63013835278/CCR3-9-164-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2334/7813012/129e8ba87bdf/CCR3-9-164-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2334/7813012/c76737748466/CCR3-9-164-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2334/7813012/fc7cf9d94d50/CCR3-9-164-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2334/7813012/51a22befc968/CCR3-9-164-g005.jpg

相似文献

1
Awake ECMO without anticoagulation for nearly completely obstructive squamous cell carcinoma of the trachea.无抗凝的清醒体外膜肺氧合用于治疗几乎完全阻塞性气管鳞状细胞癌。
Clin Case Rep. 2020 Nov 6;9(1):164-168. doi: 10.1002/ccr3.3490. eCollection 2021 Jan.
2
Veno-venous ECMO during surgical repair of tracheal perforation: A case report.气管穿孔手术修复期间的静脉-静脉体外膜肺氧合：一例报告
Int J Surg Case Rep. 2018;42:64-66. doi: 10.1016/j.ijscr.2017.11.036. Epub 2017 Nov 24.
3
Heparin-Sparing Anticoagulation Strategies Are Viable Options for Patients on Veno-Venous ECMO.肝素豁免抗凝策略是静脉-静脉 ECMO 患者的可行选择。
J Surg Res. 2019 Nov;243:399-409. doi: 10.1016/j.jss.2019.05.050. Epub 2019 Jul 2.
4
Comparison of Coagulation Parameters, Anticoagulation, and Need for Transfusion in Patients on Interventional Lung Assist or Veno-Venous Extracorporeal Membrane Oxygenation.接受介入性肺辅助或静脉-静脉体外膜肺氧合治疗的患者凝血参数、抗凝及输血需求的比较
Artif Organs. 2015 Sep;39(9):765-73. doi: 10.1111/aor.12464. Epub 2015 Apr 29.
5
A new anticoagulation strategy using recombinant human thrombomodulin in patients on veno-venous extracorporeal membrane oxygenation: a retrospective study.一项关于在接受静脉-静脉体外膜肺氧合治疗的患者中使用重组人血栓调节蛋白的新型抗凝策略的回顾性研究。
Ann Palliat Med. 2021 Feb;10(2):1834-1841. doi: 10.21037/apm-20-1487. Epub 2020 Dec 23.
6
Pre-emptive veno-venous ECMO in advanced tracheal malignancy prior to tracheal stenting.在气管支架置入术之前，对晚期气管恶性肿瘤进行预防性的静脉-静脉 ECMO。
BMJ Case Rep. 2021 Aug 17;14(8):e243596. doi: 10.1136/bcr-2021-243596.
7
Awake veno-arterial extracorporeal membrane oxygenation in patients with perioperative period acute heart failure in cardiac surgery.心脏手术围术期急性心力衰竭患者的清醒静脉-动脉体外膜肺氧合
J Thorac Dis. 2020 May;12(5):2179-2187. doi: 10.21037/jtd.2020.04.38.
8
Vascular access in ECMO.体外膜肺氧合中的血管通路
Indian J Thorac Cardiovasc Surg. 2021 Apr;37(Suppl 2):221-231. doi: 10.1007/s12055-020-00999-w. Epub 2020 Sep 17.
9
Anticoagulation and Transfusions Management in Veno-Venous Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome: Assessment of Factors Associated With Transfusion Requirements and Mortality.急性呼吸窘迫综合征行静脉-静脉体外膜肺氧合抗凝和输血管理：输血需求和死亡率相关因素评估。
J Intensive Care Med. 2019 Aug;34(8):630-639. doi: 10.1177/0885066617706339. Epub 2017 May 1.
10
"Awake Veno-arterial Extracorporeal Membrane Oxygenation" in Pediatric Cardiogenic Shock: A Single-Center Experience.小儿心源性休克中“清醒静脉 - 动脉体外膜肺氧合”：单中心经验
Pediatr Cardiol. 2015 Dec;36(8):1647-56. doi: 10.1007/s00246-015-1211-8. Epub 2015 Jun 7.

本文引用的文献

1
Clinical controversies in anticoagulation monitoring and antithrombin supplementation for ECMO.体外膜肺氧合抗凝监测和抗凝血酶补充的临床争议。
Crit Care. 2020 Jan 20;24(1):19. doi: 10.1186/s13054-020-2726-9.
2
Awake extracorporeal membrane oxygenation patients expanding the horizons.清醒体外膜肺氧合患者拓展视野。
J Thorac Dis. 2018 Jul;10(Suppl 18):S2215-S2216. doi: 10.21037/jtd.2018.06.28.
3
Spontaneous breathing during veno-venous extracorporeal membrane oxygenation.静脉-静脉体外膜肺氧合期间的自主呼吸。
J Thorac Dis. 2018 Mar;10(Suppl 5):S661-S669. doi: 10.21037/jtd.2017.10.27.
4
Anticoagulation Therapy during Extracorporeal Membrane Oxygenator Support in Pediatric Patients.小儿患者体外膜肺氧合支持期间的抗凝治疗
Chonnam Med J. 2017 May;53(2):110-117. doi: 10.4068/cmj.2017.53.2.110. Epub 2017 May 25.
5
Veno-venous extracorporeal membrane oxygenation: cannulation techniques.静脉-静脉体外膜肺氧合：插管技术。
J Thorac Dis. 2016 Dec;8(12):3762-3773. doi: 10.21037/jtd.2016.12.88.
6
Pembrolizumab for the treatment of PD-L1 positive advanced or metastatic non-small cell lung cancer.帕博利珠单抗用于治疗PD-L1阳性的晚期或转移性非小细胞肺癌。
Expert Rev Anticancer Ther. 2016;16(1):13-20. doi: 10.1586/14737140.2016.1123626.
7
Assessing bleeding risk in patients taking anticoagulants.评估服用抗凝药物患者的出血风险。
J Thromb Thrombolysis. 2013 Apr;35(3):312-9. doi: 10.1007/s11239-013-0899-7.
8
Intubation and mechanical ventilation of the asthmatic patient in respiratory failure.呼吸衰竭哮喘患者的气管插管与机械通气
Proc Am Thorac Soc. 2009 Aug 1;6(4):371-9. doi: 10.1513/pats.P09ST4.
9
Risk factors for morbidity in mechanically ventilated patients with acute severe asthma.急性重症哮喘机械通气患者发病的危险因素。
Am Rev Respir Dis. 1992 Sep;146(3):607-15. doi: 10.1164/ajrccm/146.3.607.